Search

Author/Creator Nakama, Takahiro

1. 04. Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) Administered in Meningococcal Vaccine-Naive Participants Across a Broad Age Range (2-55 Years) in Japan. (4th December 2021)

Authors:
Matsuoka, Osamu; Ujiie, Mugen; Kikuchi, Hitoshi; Chansinghakul, Danaya; Inoue, Takahiro; Varghese, Kucku; Sirisuphmitr, Nuchra; Hashiguchi, Tomoyuki; Zambrano, Betzana; Nakama, Takahiro; Frago, Carina; Jordanov, Emilia; Dhingra, Mandeep S
Journal:
Open forum infectious diseases
Issue:
Volume 8(2021)Supplement 1
Page Start:
S125
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Efficacy and safety of insulin glargine/lixisenatide fixed‐ratio combination (iGlarLixi 1:1) in Japanese patients with type 2 diabetes mellitus inadequately controlled on oral antidiabetic drugs: A randomized, 26‐week, open‐label, multicentre study: The LixiLan JP‐O2 randomized clinical trial. (16th September 2020)

Authors:
Terauchi, Yasuo; Nakama, Takahiro; Spranger, Robert; Amano, Atsushi; Inoue, Takahiro; Niemoeller, Elisabeth
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 22:Supplement 4(2020)
Page Start:
14
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Immunogenicity and safety of high-dose quadrivalent influenza vaccine in Japanese adults ≥65 years of age: a randomized controlled clinical trial. Issue 4 (2nd April 2020)

Authors:
Sanchez, Leilani; Matsuoka, Osamu; Inoue, Satoshi; Inoue, Takahiro; Meng, Ya; Nakama, Takahiro; Kato, Kumiko; Pandey, Aseem; Chang, Lee-Jah
Journal:
Human vaccines & immunotherapeutics
Issue:
Volume 16:Issue 4(2020)
Page Start:
858
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Superior immunogenicity of high-dose quadrivalent inactivated influenza vaccine versus Standard-Dose vaccine in Japanese Adults ≥ 60 years of age: Results from a phase III, randomized clinical trial. Issue 15 (6th April 2023)

Authors:
Sanchez, Leilani; Nakama, Takahiro; Nagai, Hideaki; Matsuoka, Osamu; Inoue, Satoshi; Inoue, Takahiro; Shrestha, Anju; Pandey, Aseem; Chang, Lee-Jah; De Bruijn, Iris
Journal:
Vaccine
Issue:
Volume 41:Issue 15(2023)
Page Start:
2553
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗